Endoscopic Therapy Or Surgery for Early Colon Cancer

NCT06940947 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 434

Last updated 2025-11-20

No results posted yet for this study

Summary

The trial is a randomized head-to-head comparison of the benefits, harms and burdens of endoscopic full-thickness resection (eFTR), a novel, minimally invasive endoscopic treatment modality, for early colon cancer as compared to standard-of-care surgery.

Conditions

Interventions

PROCEDURE

eFTR

endoscopic full thickness resection

PROCEDURE

Surgery

standard-of-care surgery

Sponsors & Collaborators

  • Medical University of Gdansk

    collaborator OTHER
  • Vestre Viken Hospital Trust

    collaborator OTHER
  • Medical Biometry and Epidemiology_- Universitätsklinikum Hamburg Eppendorf

    collaborator UNKNOWN
  • Institute of Oncology in Warsaw

    collaborator UNKNOWN
  • Karolinska Institutet

    collaborator OTHER
  • University Hospital, Limoges

    collaborator OTHER
  • University Hospital, Akershus

    collaborator OTHER
  • University of Roma La Sapienza

    collaborator OTHER
  • Hospital Clinic of Barcelona

    collaborator OTHER
  • Leuven University Medical Center

    collaborator UNKNOWN
  • University Hospital, Ghent

    collaborator OTHER
  • Sørlandet Hospital

    collaborator UNKNOWN
  • Northern Norway Regional Health Trust

    collaborator UNKNOWN
  • Helse Stavanger HF

    collaborator OTHER_GOV
  • Haukeland University Hospital

    collaborator OTHER
  • St. Olavs Hospital

    collaborator OTHER
  • University of Oslo

    collaborator OTHER
  • Frontier Science Foundation

    collaborator UNKNOWN
  • Norwegian Department of Health and Social Affairs

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-25
Primary Completion
2033-09-01
Completion
2033-09-01

Countries

  • Poland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06940947 on ClinicalTrials.gov